Urticaria, fever, and hypofibrinogenemia

Arthritis and Rheumatology

Volumn 66, Issue 5, 2014, Pages 1377-

  Mohr, Verena ^a   Schulz, Ansgar ^a   Lohse, Peter ^b   Schumann, Christian ^a   Debatin, Klaus Michael ^a   Schuetz, Catharina ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Institute of Laboratory Medicine and Human Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; CANAKINUMAB; DEXAMETHASONE; FIBRIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SERUM AMYLOID A;

ARTHRALGIA; BICYTOPENIA; BRONCHOSCOPY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; CHRONIC INFLAMMATION; CHRONIC URTICARIA; CINCA SYNDROME; CYTOPENIA; ERYTHROPHAGOCYTOSIS; EXON; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYPERFERRITINEMIA; HYPOFIBRINOGENEMIA; LYMPHADENOPATHY; MACROPHAGE ACTIVATION SYNDROME; MEDIASTINAL LYMPHADENOPATHY; MEDICAL HISTORY; NOTE; PENETRANCE; PERSONAL EXPERIENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASH; RECURRENT FEVER; RELAPSE; SCHOOL CHILD;

AFIBRINOGENEMIA; CARRIER PROTEINS; CHILD; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HETEROZYGOTE DETECTION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MUTATION; TREATMENT OUTCOME; URTICARIA;

EID: 84899757917     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38345     Document Type: Note

References (2)

1. Rowczenio DM, Trojer H, Russell T, Baginska A, Lane T, Stewart NM, et al. Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature. Arthritis Res Ther 2013; 15: R30.
2. Endres T, Hofer F, Goldbach-Mansky R, Hoffman HM, Blank N, Krause K, et al. Low-penetrance NLRP3 variants. Ped Rheum 2013; 11 Suppl 2: P321.